Delivery Order SPE2DB22D3501-SPE2DB24FVE72

Award Date 4/8/24
Potential Completion Date 4/29/24
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty pharmaceutical product. The potential value of this delivery order is $2,896.41, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $6,686.67 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML, a pharmaceutical product, with a period of performance through May 13, 2024. This award is under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary...
The U.S. Department of Defense (DoD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Somatuline Depot 120 mg/0.5 ml pharmaceuticals. The contract, valued at $2,896.41, has an ultimate completion date of April 2, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Somatuline Depot 90 mg/0.3 ml pharmaceutical products. The $6,686.67 firm-fixed-price delivery order has an ultimate completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for providing a...
Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of pharmaceutical product SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML. The contract has a potential value of $2,228.89 and a completion date of February 21, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,585.64 delivery order contract is for the provision of the prescription drug Somatuline Depot 120 mg/0.5 ml, with a period of performance through June 4, 2024. Amerisourcebergen, a subsidiary of the Cencora, Inc. corporate group, was selected for this...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,807.44, is for the delivery of Somatuline Depot 120 mg/0.5 ml medication. The contract is a firm fixed-price delivery order with a completion date of March 24, 2025. There is no set-aside designation for this award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $17,831.12, is for the delivery of Somatuline Depot 90 mg/0.3 ml medication. It is a firm fixed price, delivery order contract with an ultimate completion date of October 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
The Defense Logistics Agency (DLA) awarded a $3,951.86 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,686.67, is for the delivery of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 3, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVE72
    Delivery Order

The Department of Defense (DoD) Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Somatuline Depot 90 mg/0.3 ml pharmaceutical products. The $2,228.89 award has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a comprehensive range of medications and medical supplies to support DoD military treatment programs and facilities worldwide. No set-aside designation was used for this award.

Generated 7/8/24, 9:30 AM